vs

Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and Regency Centers (REG). Click either name above to swap in a different company.

Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $404.2M, roughly 1.2× Regency Centers). Regency Centers runs the higher net margin — 50.1% vs 6.8%, a 43.3% gap on every dollar of revenue. On growth, Regency Centers posted the faster year-over-year revenue change (8.5% vs -1.7%). Over the past eight quarters, Regency Centers's revenue compounded faster (5.4% CAGR vs -0.1%).

Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.

Regency Centers Corporation is a real estate investment trust based in Jacksonville, Florida, and is one of the largest operators of shopping centers with grocery stores as anchor tenants. As of October 21, 2020, the company owned 415 properties comprising 56-million-square feet of space. Notable properties owned by the company include Serramonte Center and a 30% interest in Village District.

MD vs REG — Head-to-Head

Bigger by revenue
MD
MD
1.2× larger
MD
$493.8M
$404.2M
REG
Growing faster (revenue YoY)
REG
REG
+10.2% gap
REG
8.5%
-1.7%
MD
Higher net margin
REG
REG
43.3% more per $
REG
50.1%
6.8%
MD
Faster 2-yr revenue CAGR
REG
REG
Annualised
REG
5.4%
-0.1%
MD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MD
MD
REG
REG
Revenue
$493.8M
$404.2M
Net Profit
$33.7M
$202.5M
Gross Margin
Operating Margin
9.9%
71.0%
Net Margin
6.8%
50.1%
Revenue YoY
-1.7%
8.5%
Net Profit YoY
10.5%
134.1%
EPS (diluted)
$0.40

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MD
MD
REG
REG
Q4 25
$493.8M
$404.2M
Q3 25
$492.9M
$387.6M
Q2 25
$468.8M
$380.8M
Q1 25
$458.4M
$380.9M
Q4 24
$502.4M
$372.5M
Q3 24
$511.2M
$360.3M
Q2 24
$504.3M
$357.3M
Q1 24
$495.1M
$363.9M
Net Profit
MD
MD
REG
REG
Q4 25
$33.7M
$202.5M
Q3 25
$71.7M
$109.4M
Q2 25
$39.3M
$106.0M
Q1 25
$20.7M
$109.6M
Q4 24
$30.5M
$86.5M
Q3 24
$19.4M
$101.5M
Q2 24
$-153.0M
$102.7M
Q1 24
$4.0M
$109.8M
Operating Margin
MD
MD
REG
REG
Q4 25
9.9%
71.0%
Q3 25
13.8%
72.7%
Q2 25
12.8%
73.8%
Q1 25
7.0%
71.8%
Q4 24
7.8%
71.1%
Q3 24
6.6%
72.5%
Q2 24
-31.3%
72.3%
Q1 24
3.2%
72.3%
Net Margin
MD
MD
REG
REG
Q4 25
6.8%
50.1%
Q3 25
14.5%
28.2%
Q2 25
8.4%
27.8%
Q1 25
4.5%
28.8%
Q4 24
6.1%
23.2%
Q3 24
3.8%
28.2%
Q2 24
-30.3%
28.7%
Q1 24
0.8%
30.2%
EPS (diluted)
MD
MD
REG
REG
Q4 25
$0.40
Q3 25
$0.84
Q2 25
$0.46
Q1 25
$0.24
Q4 24
$0.37
Q3 24
$0.23
Q2 24
$-1.84
Q1 24
$0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MD
MD
REG
REG
Cash + ST InvestmentsLiquidity on hand
$375.2M
Total DebtLower is stronger
$570.5M
$4.7B
Stockholders' EquityBook value
$865.9M
$6.9B
Total Assets
$2.2B
$13.0B
Debt / EquityLower = less leverage
0.66×
0.69×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MD
MD
REG
REG
Q4 25
$375.2M
Q3 25
$340.1M
Q2 25
$224.7M
Q1 25
$99.0M
Q4 24
$229.9M
Q3 24
$103.8M
Q2 24
$19.4M
Q1 24
$8.0M
Total Debt
MD
MD
REG
REG
Q4 25
$570.5M
$4.7B
Q3 25
$577.2M
$4.9B
Q2 25
$583.9M
$4.8B
Q1 25
$590.5M
$4.6B
Q4 24
$597.1M
$4.4B
Q3 24
$4.4B
Q2 24
$4.4B
Q1 24
$4.4B
Stockholders' Equity
MD
MD
REG
REG
Q4 25
$865.9M
$6.9B
Q3 25
$890.7M
$6.8B
Q2 25
$833.8M
$6.7B
Q1 25
$789.2M
$6.7B
Q4 24
$764.9M
$6.7B
Q3 24
$732.5M
$6.8B
Q2 24
$706.5M
$6.8B
Q1 24
$856.2M
$7.0B
Total Assets
MD
MD
REG
REG
Q4 25
$2.2B
$13.0B
Q3 25
$2.2B
$13.1B
Q2 25
$2.1B
$12.7B
Q1 25
$2.0B
$12.6B
Q4 24
$2.2B
$12.4B
Q3 24
$2.1B
$12.4B
Q2 24
$2.0B
$12.4B
Q1 24
$2.2B
$12.7B
Debt / Equity
MD
MD
REG
REG
Q4 25
0.66×
0.69×
Q3 25
0.65×
0.72×
Q2 25
0.70×
0.72×
Q1 25
0.75×
0.69×
Q4 24
0.78×
0.66×
Q3 24
0.65×
Q2 24
0.64×
Q1 24
0.63×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MD
MD
REG
REG
Operating Cash FlowLast quarter
$114.1M
$203.9M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
3.39×
1.01×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MD
MD
REG
REG
Q4 25
$114.1M
$203.9M
Q3 25
$137.3M
$218.7M
Q2 25
$137.2M
$244.0M
Q1 25
$-117.5M
$161.0M
Q4 24
$133.0M
$191.4M
Q3 24
$91.8M
$227.6M
Q2 24
$107.0M
$203.5M
Q1 24
$-125.2M
$167.8M
Cash Conversion
MD
MD
REG
REG
Q4 25
3.39×
1.01×
Q3 25
1.91×
2.00×
Q2 25
3.49×
2.30×
Q1 25
-5.66×
1.47×
Q4 24
4.36×
2.21×
Q3 24
4.72×
2.24×
Q2 24
1.98×
Q1 24
-31.03×
1.53×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MD
MD

Health Care Patient Service$421.6M85%
Hospitals Contracts$70.0M14%
Other$2.2M0%

REG
REG

Shopping Centers$418.0M103%
Propertymanagementservices$4.1M1%
Assetmanagementservices$1.7M0%

Related Comparisons